Prophylactic antithrombotic therapy after orthopedic surgery using bemiparin, a second-generation low molecular weight heparin;Profilaxis antitrombótica poscirugía ortopédica con bemiparina, heparina de bajo peso molecular de segunda generación

Revista Espanola de Anestesiologia y Reanimacion

Volumn 48, Issue 6, 2001, Pages 258-263

  Planes A ^a   Vochelle, N ^a   Gonzalez de Suso M J ^a   Claracq, J P ^a  

^a Clinique Radio Chirurgicale du Mail   (France)

Author keywords

Bemiparin; Low molecular weight heparin; Thromboprophylaxis; Total Hip Replacement

Indexed keywords

BEMIPARIN; BLOOD CLOTTING FACTOR 10A; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CHEMOPROPHYLAXIS; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMATOMA; HIP SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; POSTOPERATIVE HEMORRHAGE; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS; TOTAL HIP PROSTHESIS;

ARTHROPLASTY, REPLACEMENT, HIP; CONFIDENCE INTERVALS; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; VENOUS THROMBOSIS;

EID: 0034749042     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Prevention of venous thromboembolism
2. Total hip replacement and deep vein thrombosis: A venographic and necropsy study
3. Low molecular weight heparin
4. Prevention of Venous Thromboembolism International Consensus Statement (Guidelines according to scientific evidence)
5. Prevention of postoperative venous thrombosis: A randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement
6. A comparative, doubleblind, randomised trial of a new second generation LMWH (Bemiparin) and UFH in the prevention of post-operative venous thromboembolism
7. Starting prophylaxis for venous thromboembolism postoperatively
8. Heparinas de bajo peso molecular: Implicaciones en anestesia y reanimación
9. Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement
10. Efficacy and safety of a perioperative enoxaparin regimen in total hip replacement under various anesthesias
11. Epidural regional anaesthesia and low molecular weight heparin
12. Low molecular weight heparin for thromboprophylaxis and epidural/spinal anaesthesia- Is there a risk?
13. Anticoagulants and spinal-epidural anesthesia
14. Neurological complications after anaesthesia: A follow up of 18,000 spinal and epidural anaesthetics performed over three years
15. Low molecular weight heparin: Biochemistry, pharmacology, prophylaxis regimens, and guidelines for regional anaesthetic management
16. Spinal and epidural hematoma and low-molecular-weight heparin
17. Is anticoagulation and central neural blockade a safe combination?
18. Central neural block and thromboprophylaxis - Is there a problem?
19. Spinal or epidural anaesthesia with low molecular weight heparin for thromboprophylaxis requires careful postoperative neurological observation
20. Risk of combining low molecular weight heparin for thromboprophylaxis and epidural or spinal anesthesia
21. Anticoagulants, antiplatelets therapy and neuraxis blockade
22. Safety of neuraxial anesthesia in patients receiving perioperative low-molecular-weight heparin for thromboprophylaxis
23. Roentgen diagnosis of venous thrombosis in the leg
24. Bleeding classification in clinical trials- observer variability and clinical relevance
25. Transaminase increase: A largely unknown side-effect of heparin treatment
26. Transaminase elevations in patients receiving bovine or porcine heparin
27. Heparin-induced increase in serum levels of aminotransferases: A controlled clinical trial
28. Heparin interference in the measurement of gamma-glutamyltransfemse activity with the Scandinavian and the IFCC recommended method
29. Elimination of heparin interference in the determination of gamma-GT
30. Heparin-induced increase in plasma and serum gamma-glutamyl transpeptidase activity
31. Prevention of deep vein thrombosis after total hip replacement: The effect of low-molecular-weight heparin with spinal and general anaesthesia
32. Low molecular weight heparin associated with spinal anaesthesia and gradual compression stockings in total hip replacement surgery
33. Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery
34. Low molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients
35. Comparison of two low molecular weight heparins for the preventions of postoperative venous thromboembolism after elective hip surgery
36. Prevention of deep vein thrombosis after hip replacement: Comparison between two low molecular weight heparins, tinzaparinand enoxaparin